Personalizing Therapy in Idiopathic Pulmonary Fibrosis: A Glimpse of the Future?

Jonathan A Kropski¹, William E Lawson^{1

2}, Timothy S Blackwell^{1

2

3

4}

Affiliations

¹ 1 Department of Medicine Vanderbilt University School of Medicine Nashville, Tennessee.
² 2 Department of Veterans Affairs Medical Center Nashville, Tennessee.
³ 3 Department of Cell and Developmental Biology and.
⁴ 4 Department of Cancer Biology Vanderbilt University School of Medicine Nashville, Tennessee.

Editorial

Jonathan A Kropski et al. Am J Respir Crit Care Med. 2015.

. 2015 Dec 15;192(12):1409-11.

doi: 10.1164/rccm.201509-1789ED.

Jonathan A Kropski¹, William E Lawson^{1

2}, Timothy S Blackwell^{1

2

3

4}

¹ 1 Department of Medicine Vanderbilt University School of Medicine Nashville, Tennessee.
² 2 Department of Veterans Affairs Medical Center Nashville, Tennessee.
³ 3 Department of Cell and Developmental Biology and.
⁴ 4 Department of Cancer Biology Vanderbilt University School of Medicine Nashville, Tennessee.

No abstract available

Comment on

TOLLIP, MUC5B, and the Response to N-Acetylcysteine among Individuals with Idiopathic Pulmonary Fibrosis.
Oldham JM, Ma SF, Martinez FJ, Anstrom KJ, Raghu G, Schwartz DA, Valenzi E, Witt L, Lee C, Vij R, Huang Y, Strek ME, Noth I; IPFnet Investigators. Oldham JM, et al. Am J Respir Crit Care Med. 2015 Dec 15;192(12):1475-82. doi: 10.1164/rccm.201505-1010OC. Am J Respir Crit Care Med. 2015. PMID: 26331942 Free PMC article.

1. King TE, Jr, Bradford WZ, Castro-Bernardini S, Fagan EA, Glaspole I, Glassberg MK, Gorina E, Hopkins PM, Kardatzke D, Lancaster L, et al. ASCEND Study Group. A phase 3 trial of pirfenidone in patients with idiopathic pulmonary fibrosis. N Engl J Med. 2014;370:2083–2092. - PubMed
1. Richeldi L, du Bois RM, Raghu G, Azuma A, Brown KK, Costabel U, Cottin V, Flaherty KR, Hansell DM, Inoue Y, et al. INPULSIS Trial Investigators. Efficacy and safety of nintedanib in idiopathic pulmonary fibrosis. N Engl J Med. 2014;370:2071–2082. - PubMed
1. Raghu G, Anstrom KJ, King TE, Jr, Lasky JA, Martinez FJ Idiopathic Pulmonary Fibrosis Clinical Research Network. Prednisone, azathioprine, and N-acetylcysteine for pulmonary fibrosis. N Engl J Med. 2012;366:1968–1977. - PMC - PubMed
1. Demedts M, Behr J, Buhl R, Costabel U, Dekhuijzen R, Jansen HM, MacNee W, Thomeer M, Wallaert B, Laurent F, et al. IFIGENIA Study Group. High-dose acetylcysteine in idiopathic pulmonary fibrosis. N Engl J Med. 2005;353:2229–2242. - PubMed
1. Martinez FJ, de Andrade JA, Anstrom KJ, King TE, Jr, Raghu G Idiopathic Pulmonary Fibrosis Clinical Research Network. Randomized trial of acetylcysteine in idiopathic pulmonary fibrosis. N Engl J Med. 2014;370:2093–2101. - PMC - PubMed